Arrow Research search

Author name cluster

Cristina Concetti

Possible papers associated with this exact author name in Arrow. This page groups case-insensitive exact name matches and is not a full identity disambiguation profile.

2 papers
1 author row

Possible papers

2

YNICL Journal 2026 Journal Article

Altered microstate dynamics in Functional Neurological Disorder

  • Irene Lozzi
  • Cristina Concetti
  • Natascha Stoffel
  • Michael Mouthon
  • Miriam Braga
  • Michele Tinazzi
  • Mirta Fiorio
  • Selma Aybek

BACKGROUND: Functional Neurological Disorder (FND) presents with disabling and heterogeneous motor, sensory, and cognitive symptoms despite the absence of gross structural pathology. A key question is whether symptoms reflect disruptions in the intrinsic organization of brain networks. Electroencephalography (EEG) offers a high temporal resolution view of ongoing dynamics, making it a powerful means to probe such mechanisms. METHODS: We applied a seven-class microstate decomposition to resting-state EEG from 39 patients with FND and 47 matched healthy controls to characterize the temporal dynamics of brain activity. Microstate were labelled A-G according to established topographies. Symptom severity was assessed with the Simplified-Functional Movement Disorder Rating Scale, and correlations were tested. Logistic regression was used to assess group discrimination, with accuracy quantified by the area under the curve. RESULTS: Compared to controls, patients with FND exhibit significantly reduced duration of microstate G, associated with sensorimotor integration. This alteration correlated negatively with symptom severity scores and moderately discriminated groups. Transition probabilities analyses uncovered distinct patterns among microstates A, B and C, suggesting both an exaggerated shift from arousal-related to visual imagery networks and resistance to engage in self-referential processing. CONCLUSIONS: Our findings provide the first direct evidence of disrupted resting-state microstate organization across a heterogeneous FND cohort.

YNICL Journal 2025 Journal Article

Modulating the sense of agency in functional neurological disorder using real-time fMRI neurofeedback: a proof-of-concept study

  • Eliane Müller
  • Serafeim Loukas
  • Salome Häuselmann
  • Cristina Concetti
  • Dimitri Van De Ville
  • Nicolas Gninenko
  • Selma Aybek

BACKGROUND: Disrupted sense of agency (SoA), the perceived loss of control over one's actions, is common in functional neurological disorder (FND) and linked to abnormal activation in agency-related networks, particularly the right temporoparietal junction (rTPJ). This proof-of-concept study tested whether fMRI neurofeedback (NF) could enhance SoA in FND by targeting the rTPJ. METHODS: In this single-arm feasibility study, 18 patients with mixed FND symptoms completed three NF trainings during an adaptive visuomotor task, receiving intermittent visual feedback of their rTPJ activity. Pre- and post-training assessments included subjective agency ratings, neuroimaging during a transfer task, and clinical evaluations. RESULTS: Group-level subjective agency significantly increased after training (p = 0.0083), driven by responders (n = 8) who exhibited rTPJ (p = 0.042) and supplementary motor area (SMA) upregulation (p = 0.015) in the first session, alongside consistent task engagement. Behavioral gains coincided with trend-level decreases in rTPJ-dorsolateral prefrontal cortex (dlPFC) connectivity (p = 0.098), while non-responders showed reduced rTPJ-SMA connectivity (p = 0.008). No group-level clinical improvements were observed, but higher initial rTPJ (p = 0.03, ρ = -0.78) and dlPFC (p = 0.03, ρ = -0.75) activation were negatively associated with changes in self-reported core symptoms. CONCLUSION: NF from rTPJ activity is feasible in FND and may enhance explicit SoA in a subset of patients through early neural modulation and sustained engagement. High inter-individual variability underscores the need for sham-controlled trials with optimized, engaging feedback designs and longitudinal monitoring to identify patients who could benefit from NF.

v2026.09.13